In Segment A, contributors will get diverse doses and schedules of oral ABBV-744 tablet to determine Secure dosing program. Additional contributors might be enrolled in the identified monotherapy dosign routine. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will probably be gi